Finch Therapeutics Group, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Finch Therapeutics Group, Inc. Return On Assets for the quarter ending June 30, 2024 was -26.9 %, a 75.5% increase year-over-year.
  • Finch Therapeutics Group, Inc. annual Return On Assets for 2023 was -115 %, a 96% decline from 2022.
  • Finch Therapeutics Group, Inc. annual Return On Assets for 2022 was -58.5 %, a 145% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -26.9 +83.1 +75.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -28.1 +64.5 +69.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -115 -56.2 -96% Oct 1, 2023 Dec 31, 2023
Q3 2023 -107 -56.8 -113% Jul 1, 2023 Sep 30, 2023
Q2 2023 -110 -75.8 -221% Apr 1, 2023 Jun 30, 2023
Q1 2023 -92.6 -62.5 -208% Jan 1, 2023 Mar 31, 2023
Q4 2022 -58.5 -34.6 -145% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50.4 -27.6 -121% Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.9 Oct 1, 2021 Dec 31, 2021
Q3 2021 -22.8 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.